02837nas a2200253 4500008004100000245011300041210006900154260001900223300001200242490000600254520204300260653001902303653001302322653002302335653001302358653001502371653001602386653001702402653003102419100002502450700002402475700002202499856006202521 2019 eng d00aEconomic Outcomes of Pharmacist Prescribing Total Parenteral Nutrition at Ministry of Health in Saudi Arabia0 aEconomic Outcomes of Pharmacist Prescribing Total Parenteral Nut cSeptember 2019 aS35-S390 v53 a

Objectives: In 2013, The General Administration of Pharmaceutical Care started the National Total Parenteral Nutrition (TPN) Program in Saudi Arabia. The pharmacist can provide neonates’ TPN services. In this study, we aimed to estimate the economic outcomes and cost avoidance in relation to pharmacist prescribing TPN. Methods: A total of 20 hospitals provide TPN services for neonates, pediatrics and adult patients. Cost avoidance stimulation in relation to the pharmacist prescribing and running neonates, pediatrics TPN services and replacement physician of a pharmacist as prescriber with adults TPN services. All costs were calculated by using US dollar currency. One-way sensitivity analysis was conducted for a list of discount prices and variety of wage cost with 10–20%. Results: The total annual estimated cost avoidance of pharmacist by providing TPN services for 20 hospitals for all types of patients was (1,569,865.40 USD) and with a discount of 10-20%, it was (1,412,878.86-1,255,892.32 USD). Of those, the total annual estimated cost avoidance of pharmacist providing the TPN services for 20 hospitals for neonates was (562,027.40 USD) and with discount of 10-20%, it was (505,824.66- 449,621.92 USD). The total annual estimated cost avoidance of pharmacist providing the TPN services for 20 hospitals for adults was (523,337.00 USD) and with discount of 10-20%, it was (471,003.30- 418,669.60 USD). The total annual estimated cost avoidance of pharmacist providing the TPN services for 20 hospitals for pediatrics was (484,501.00 USD) and with a discount of 10-20%, it was (436,050.90- 387,600.80 USD). Conclusion: The pharmacist prescribing TPN prevents high economic burden on the healthcare system at Ministry of Health. Expanding the role of a pharmacist in the nutrition support services with an emphasis on prescribing TPN services is highly recommended at healthcare institutions in the Kingdom of Saudi Arabia.

10aCost avoidance10aEconomic10aMinistry of Health10aOutcomes10aPharmacist10aPrescribing10aSaudi Arabia10aTotal Parenteral Nutrition1 aAlomi, Yousef, Ahmed1 aAlanazi, Mona, Awad1 aBahadig, Faiz, A. uhttps://ptbreports.org/article/2019/5/3s/105530ptb2019535